Biopharmaceutical CMO & CRO Market by Product Type (Biologics, Biosimilars), by Application (Contract Manufacturing, Contract Research) - Overall In-depth Analysis, Global Market Share, Top Trends, Professional & Technical Industry Insights 2020 - 2026

Chemicals and Materials Syndicate Market Research Pages: 125 Report ID: 2

COVID-19

To Understand How COVID-19 Impact is Covered in this Report

The global Biopharmaceutical CMO & CRO market size was valued at USD XX million in 2019 and is predicted to register a CAGR of XX% from 2020 to 2026.

The report covers the current estimate and forecast for Biopharmaceutical CMO & CRO market on a global and regional level. The report provides an in-depth analysis of the Biopharmaceutical CMO & CRO market for the period 2016 – 2026, wherein 2019 is the base year and the period from 2020 to 2026 is the forecast period. Data for 2016- 2018 has been included as historical information. The study provides a holistic perspective on market growth, throughout the above forecast period in terms of revenue estimates (in US$ MN), across different geographies, which includes North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and Latin America (LATAM).

The report provides cross-sectional analysis of the Biopharmaceutical CMO & CRO market in terms of market estimates and forecasts for all the segments across different geographic regions. The report covers all the prevalent trends and technologies playing a major role in the growth of the Biopharmaceutical CMO & CRO market over the forecast period. It also highlights various drivers, restraints, and opportunities expected to influence the market growth during the said period.

The study offers market attractiveness analysis and the Porter’s Five Forces model analysis to help the client gauge the competitive landscape of major vendors of the global Biopharmaceutical CMO & CRO market. This comprehensive study also provides a detailed analysis and overview of each segments included in the study.

In order to give the users of this report, a comprehensive view of the Biopharmaceutical CMO & CRO market, we have included a detailed competitive scenario and product portfolio of the key vendors spread across various geographies. The report study also includes PESTEL analysis and SWOT analysis of the industry. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness in terms of investment opportunity and incremental value growth.

Regional Insights

The report segments the market by major types, applications, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2020 to 2026.

The regional segmentation includes the historic and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. These regions are further divided into countries such as U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Japan, India, China, Brazil, GCC countries, South Africa among others.

Biopharmaceutical CMO & CRO Market Share Insights

Key industry participants analyzed and profiled in this study includes Lonza, Boehringer Ingelheim GmbH, Rentschler Biotechnologie GmbH, Inno Biologics Sdn Bhd, JRS Pharma (Celonic GmbH), BIOMEVA GmbH, ProBioGen, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., TOYOBO CO. LTD, Samsung BioLogics, Patheon, CMC Biologics, Binex Co. Ltd., AbbVie Inc., WuXi Biologics. among others.

Scope of the report

Attribute Details
Base year for estimation 2019
Actual estimates/Historical data 2016 - 2018
Forecast period 2020 - 2026
Market representation Revenue in USD Million & CAGR from 2020 to 2026
Regional scope North America, Europe, Asia Pacific, Central & South America & MEA
Country scope U.S., Germany, U.K., Italy, China, Japan, Brazil
Report coverage       Revenue forecast, company share, competitive landscape, growth factors and trends
Free customization scope (equivalent to 5 analyst working days) If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

 

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends and opportunities in each of the sub-segments from 2016 to 2026. For the purpose of this study, Syndicate Market Research has segmented the global Biopharmaceutical CMO & CRO market report on the basis of product type, application, and region:

Global Biopharmaceutical CMO & CRO Market: Product Type Segment Analysis

  • Biologics
  • Biosimilars

Global Biopharmaceutical CMO & CRO Market: Application Segment Analysis

  • Contract Manufacturing
  • Contract Research

Global Biopharmaceutical CMO & CRO Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Chile
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
  1. Preface
    1. Report Description and Scope
    2. Research Scope
    3. Research Methodology
      1. Market Research Process
      2. Market Research Methodology
  2. Executive Summary
    1. Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
    2. Biopharmaceutical CMO & CRO Market: Snapshot
  3. Biopharmaceutical CMO & CRO - Industry Analysis
    1. Biopharmaceutical CMO & CRO: Market Dynamics
    2. Market Drivers
      1. Driver 1
      2. Driver 2
    3. Restraints
      1. Restraint 1
      2. Restraint 2
    4. Opportunity
      1. Government funding and support
    5. Porter’s Five Forces Analysis
    6. Market Attractiveness Analysis
      1. Market attractiveness analysis By Product
      2. Market attractiveness analysis By Application
      3. Market attractiveness analysis by Region
  4. Biopharmaceutical CMO & CRO Market - Competitive Landscape
    1. Company market share analysis
      1. Global Biopharmaceutical CMO & CRO Market: company market share, 2019
    2. Strategic development
      1. Acquisitions & mergers
      2. New Product launches
      3. Agreements, partnerships, collaborations and joint ventures
      4. Research and development and Regional expansion
    3. Price trend analysis
  5. Global Biopharmaceutical CMO & CRO Market -Product Type Analysis
    1. Global Biopharmaceutical CMO & CRO Market overview: By Product Type
      1. Global Biopharmaceutical CMO & CRO Market share, By Product Type,2019 and 2026
    2. Biologics
      1. Global Biopharmaceutical CMO & CRO Market by Biologics, 2016-2026 (USD Million)
    3. Biosimilars
      1. Global Biopharmaceutical CMO & CRO Market by Biosimilars, 2016-2026 (USD Million)
  6. Global Biopharmaceutical CMO & CRO Market -Application Analysis
    1. Global Biopharmaceutical CMO & CRO Market overview: By Application
      1. Global Biopharmaceutical CMO & CRO Market share, By Application,2019 and 2026
    2. Contract Manufacturing
      1. Global Biopharmaceutical CMO & CRO Market by Contract Manufacturing, 2016-2026 (USD Million)
    3. Contract Research
      1. Global Biopharmaceutical CMO & CRO Market by Contract Research, 2016-2026 (USD Million)
  7. Global Biopharmaceutical CMO & CRO Market - Regional Analysis
    1. Global Biopharmaceutical CMO & CRO Market overview: by Region
      1. Global Biopharmaceutical CMO & CRO Market share, by Region, 2019 and 2026
    2. North America
      1. North America Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
      1. North America Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      1. North America Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      1. U.S. Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      2. U.S. Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      3. Canada Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      4. Canada Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      5. Mexico Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      6. Mexico Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
    3. Europe
      1. Europe Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
      1. Europe Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      1. Europe Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      1. UK Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      2. UK Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      3. Germany Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      4. Germany Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      5. France Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      6. France Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      7. Italy Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      8. Italy Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      9. Spain Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      10. Spain Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      11. Netherlands Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      12. Netherlands Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      13. Rest of Europe Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      14. Rest of Europe Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
    4. Asia Pacific
      1. Asia Pacific Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
      1. Asia Pacific Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      1. Asia Pacific Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      1. China Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      2. China Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      3. Japan Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      4. Japan Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      5. India Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      6. India Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      7. Australia Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      8. Australia Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      9. South East Asia Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      10. South East Asia Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      11. South Korea Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      12. South Korea Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      13. Rest of Asia Pacific Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      14. Rest of Asia Pacific Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
    5. Latin America
      1. Latin America Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
      1. Latin America Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      1. Latin America Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      1. Brazil Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      2. Brazil Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      3. Argentina Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      4. Argentina Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      5. Chile Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      6. Chile Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      7. Rest of Latin America Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      8. Rest of Latin America Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
    6. Middle East & Africa
      1. Middle East & Africa Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
      1. Middle East & Africa Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      1. Middle East & Africa Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      1. GCC Countries Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      2. GCC Countries Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      3. Nigeria Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      4. Nigeria Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      5. South Africa Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      6. South Africa Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
      7. Rest of Middle East & Africa Biopharmaceutical CMO & CRO Market revenue, By Product Type, 2016-2026 (USD Million)
      8. Rest of Middle East & Africa Biopharmaceutical CMO & CRO Market revenue, By Application, 2016-2026 (USD Million)
  8. Company Profiles
    1. Lonza
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    2. Boehringer Ingelheim GmbH
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    3. Rentschler Biotechnologie GmbH
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    4. Inno Biologics Sdn Bhd
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    5. JRS Pharma (Celonic GmbH)
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    6. BIOMEVA GmbH
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    7. ProBioGen
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    8. FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    9. TOYOBO CO. LTD
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    10. Samsung BioLogics
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    11. Patheon
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    12. CMC Biologics
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    13. Binex Co. Ltd.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    14. AbbVie Inc.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments
    15. WuXi Biologics.
      1. Overview
      2. Financials
      3. Product Portfolio
      4. Business Strategy
      5. Recent Developments

 

List of Figures

  1. Market research process
  2. Market research methodology
  3. Global Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
  4. Porter’s Five Forces Analysis
  5. Global Biopharmaceutical CMO & CRO Market attractiveness, By Product Type
  6. Global Biopharmaceutical CMO & CRO Market attractiveness, By Application
  7. Global Biopharmaceutical CMO & CRO market share, By Product Type, 2019 and 2026
  8. Global Biopharmaceutical CMO & CRO Market by Biologics, 2016-2026 (USD Million)
  9. Global Biopharmaceutical CMO & CRO Market by Biosimilars, 2016-2026 (USD Million)
  10. Global Biopharmaceutical CMO & CRO market share, By Application, 2019 and 2026
  11. Global Biopharmaceutical CMO & CRO Market by Contract Manufacturing, 2016-2026 (USD Million)
  12. Global Biopharmaceutical CMO & CRO Market by Contract Research, 2016-2026 (USD Million)
  13. Global Biopharmaceutical CMO & CRO Market share, by Region, 2019 and 2026
  14. North America Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
  15. Europe Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
  16. Asia Pacific Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
  17. Latin America Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)
  18. Middle East & Africa Biopharmaceutical CMO & CRO Market, 2016-2026 (USD Million)

 

List of Tables

  1. Global Biopharmaceutical CMO & CRO Market: snapshot
  2. Drivers of the Biopharmaceutical CMO & CRO Market: impact analysis
  3. Restraints of the Biopharmaceutical CMO & CRO Market: impact analysis
  4. North America Biopharmaceutical CMO & CRO Market revenue, By Product Type,2016-2026 (USD Million)
  5. North America Biopharmaceutical CMO & CRO Market revenue, By Application,2016-2026 (USD Million)
  6. Europe Biopharmaceutical CMO & CRO Market revenue, By Product Type,2016-2026 (USD Million)
  7. Europe Biopharmaceutical CMO & CRO Market revenue, By Application,2016-2026 (USD Million)
  8. Asia Pacific Biopharmaceutical CMO & CRO Market revenue, By Product Type,2016-2026 (USD Million)
  9. Asia Pacific Biopharmaceutical CMO & CRO Market revenue, By Application,2016-2026 (USD Million)
  10. Latin America Biopharmaceutical CMO & CRO Market revenue, By Product Type,2016-2026 (USD Million)
  11. Latin America Biopharmaceutical CMO & CRO Market revenue, By Application,2016-2026 (USD Million)
  12. Middle East & Africa Biopharmaceutical CMO & CRO Market revenue, By Product Type,2016-2026 (USD Million)
  13. Middle East & Africa Biopharmaceutical CMO & CRO Market revenue, By Application,2016-2026 (USD Million)
  • Lonza
  • Boehringer Ingelheim GmbH
  • Rentschler Biotechnologie GmbH
  • Inno Biologics Sdn Bhd
  • JRS Pharma (Celonic GmbH)
  • BIOMEVA GmbH
  • ProBioGen
  • FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
  • TOYOBO CO. LTD
  • Samsung BioLogics
  • Patheon
  • CMC Biologics
  • Binex Co. Ltd.
  • AbbVie Inc.
  • WuXi Biologics.

Request Sample

Your personal details are safe and secured with us. Privacy Policy

An Overview on Research Methodology used at Syndicate Market Research:

1.1 Research Methodology

The process of market research at Syndicate Market Research is an iterative in nature and usually follows following path. Information from secondary is used to build data models, further the results obtained from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new information is again incorporated into data model. The process continues till desired level of information is not generated.

To calculate the market size, the report considers the revenue generated from the sales of the market providers. The revenue generated from the sales of market is calculated through primary and secondary research. The key players operating in the market across the globe are identified through secondary research and a corresponding detailed analysis of the top vendors in the market is done. The market size calculation also includes clinical trial phase segmentation determined using secondary sources and verified through primary sources.

1.2 Secondary Research

The secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • Internal and external proprietary databases, relevant patent and regulatory databases
  • National government documents, statistical databases and market reports
  • News articles, press releases and web-casts specific to the companies operating in the market

The sources for secondary research includes but is not limited to: Factiva, Hoovers and Statista

1.3 Primary Research

We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:

  • It provides first-hand information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/ clinical trial phase managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry end users

1.4 Models

Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data types to produce estimates:

  • Demographic data: Population split by segment
  • Macro-economic indicators: GDP, etc.
  • Industry indicators: Expenditure, infrastructure, sector growth and facilities.

Data is then cross checked by the expert panel.

1.4.1 Company Share Analysis Model

Company share analysis is used to derive the size of global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps:

1.4.2 Revenue Based Modeling

Revenue based models can be built in two ways - Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.

1.5 Research Limitations

Inflation is not a part of pricing in this report. Prices of the products and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each type has been taken into account while estimating and forecasting market revenue on a global basis. Regional average price has been considered while breaking down this market by end user in each region.

Why Choose Syndicate Market Research?

  • Assured Quality

    We focus on the quality and accuracy of the report

  • Customer's Satisfaction

    Our expert team will assist with all your research needs and customize the report

  • Analyst Support

    Get you queries resolved from our expert analysts before and after purchasing the report

  • Instant delivery

    Instant delivery in the form of a PDF/PPT/Word Doc to your email address, within 12 hours after receiving the full payment.

  • Inimitable Expertise

    Analysts will provide deep insights about the reports

  • Privacy Policy

    * We value your privacy and will never rent or sell your email address.

Our Client

Syndicated market research
Exceptional Market Report

Comprehensive & Focused Market Reports Large Archive of Excellent Market and Industry Analysis Reports that Deliver Business Intelligence.

Domain Specific Analytics
Secured Payment Options

Safe & Secure Payment Solutions Enabled by SSL, we provide you numerous safe payment options for
risk-free transactions.

Customized Research Programme
Premium Customer Service

Superior Customer Experience We serve our
customers through calls, emails and live chats for 365 days, 24x7.